Abivax S.A.
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 22 | Q1 23 | Q2 23 | Q4 23 | Q2 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | +91.2% | -13.0% | -27.9% | -18.7% | -28.3% | +445.0% | +0.0% | -16.1% | -15.5% | |
| – | +260.3% | +0.0% | +119.4% | -15.0% | -29.8% | -22.3% | -35.1% | +619.3% | +0.0% | -17.1% | -16.7% | |
| – | – | – | +120.3% | -11.8% | -35.1% | -28.2% | -41.2% | +867.6% | -12.4% | -7.6% | -18.7% | |
| – | – | – | +128.2% | -14.8% | -35.1% | – | – | – | – | – | – | |
| – | +52.7% | +0.0% | +50.4% | -8.2% | -10.7% | – | – | – | – | – | – | |
| – | – | – | -293.7% | – | – | – | – | – | – | – | – | |
| – | -11.4% | +0.0% | – | – | – | – | – | – | – | – | – | |
| – | – | – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | 0.0% | +0.0% | +0.0% | |
| – | – | – | 0.0% | +0.0% | 0.0% | +0.0% | +0.0% | 0.0% | 0.0% | +0.0% | +0.0% | |
| – | – | – | +44.7% | +20.6% | +4.2% | +5.4% | -3.2% | -16.1% | +0.0% | -16.5% | -18.4% | |
| – | -10.2% | 0.0% | +90.7% | -9.2% | +16.1% | +13.9% | +6.3% | -29.9% | +0.0% | -21.0% | +15.2% | |
| – | – | – | +223.8% | +21.9% | +14.9% | – | – | – | – | – | – | |
| – | +90.2% | -48.0% | +208.5% | -35.3% | +43.4% | +29.0% | -36.1% | -60.3% | +161.6% | -73.5% | +83.3% | |
| – | – | – | +82.7% | – | – | -9.9% | -26.0% | -54.3% | – | – | – | |
| – | – | – | +143.5% | -35.5% | -67.9% | -116.2% | – | – | -11.0% | -5.6% | -14.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | +34.5% | +30.3% | +0.4% | +0.4% | 0.0% | +22.7% | -10.7% | +14.0% | +0.4% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.